GL1X · GenesisL1 explorer

Research workbench

6RST: TBK1 in complex with inhibitor compound 24

Analyse 6RST: TBK1 in complex with inhibitor compound 24 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6RST
Type
protein
Length
629 residues
Chains
1
Method
x-ray diffraction
Authors
Panne, D., Hillig, R.C., Rengachari, S.
Deposited
05/22/19
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.29
Source
Homo sapiens
Molecule
Serine/threonine-protein kinase TBK1
EC
2.7.11.1
UniProt
Q9UHD2
Ligands
KHQ
Pockets
6 · best druggability 0.72

Structure

x-ray diffraction · resolution 3.29 · 1 distinct chain · 52% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine/threonine-protein kinase TBK1 (EC 2.7.11.1)protein62952% helix, 15% strandQ9UHD2

Ligands and binding sites

  • KHQ · 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15780.720.8061KHQ
24350.700.8141empty
3780.600.8922empty
42300.490.7432empty
5880.380.7618empty

Compared structures

  • 6RST · TBK1 in complex with inhibitor compound 24 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UHD2 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase TBK1 (Q9UHD2) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

Other records of 6RST

  • 6RST-2 · MolNFT v1 / PDB · TBK1 in complex with inhibitor compound 24

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.